Veterinary Biologics Market
Market Insights on Veterinary Biologics covering sales outlook, demand forecast & up-to-date key trends
Veterinary Biologics Market By Product (Vaccines, Bacterial Extracts, Monoclonal Antibody, Immunomodulatory and Allergic Extract), Animal (Companion Animals, Livestock and Equine), Distribution Channel (Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes and Retail Pharmacies) & Region - Forecast 2022 - 2029
Veterinary Biologics Market Snapshot (2022-2029)
[232 Pages Report] The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is expected to reach US$ 18.2 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
Veterinary Biologics Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
USD 10.6 Bn |
|
Market Value 2029 |
USD 18.2 Bn |
|
CAGR 2022-2029 |
6.9% |
|
Key Players |
The key players are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.) |
|
Share of Top 5 Countries |
55.7% |
Growing demand for processed food items, increasing incidence of foodborne and zoonotic diseases, increasing awareness of pet health in developed and developing countries, improving adoption of inducing “herd immunity” in smaller animals are primary factors boosting growth of the veterinary biologics market.
Moreover, the veterinary healthcare industry is seeing demand for protozoan parasitic vaccines from countries in various regions. All these factors are expected to drive the market growth in forecast period.
Veterinary biologics market holds nearly 36.3% market value share of the US$ 29.2 Bn veterinary medicine market in 2021. In addition, manufacturers in the veterinary biologics market take comprehensive efforts to establish direct customer relations in order to enhance their relationship and trust which leads to the growth of veterinary biologics market.
Global animal production has reduced by 15%–20% annually, mainly due to rising incidence of foodborne and zoonotic diseases. With growing awareness about zoonotic diseases such as brucellosis, bird flu and swine flu, farm owners are increasingly inclined towards proper care of livestock through effective vaccination.
For instances, According to the European Food Safety Authority (EFSA), around 320,000 cases of foodborne and zoonotic diseases are reported each year in the European Union. Campylobacteriosis was the most commonly observed zoonosis in animals, which affected 220,209 people in the EU, due to consumption of infected broiler meat.
Driven by this, sales of veterinary biologics are expected to rise at a 6.9% CAGR through 2029.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1 – 2021 |
6.99% |
|
H1 – 2022 Projected |
6.91% |
|
H1 – 2022 Outlook |
6.81% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change– H1, 2022 (O) – H1, 2021 |
(-) 18 ↓ |
According to Future Market Insights’ Analysis, the global veterinary biologics market observed a reduced change in the Basis Point Share (BPS) by nearly 18 BPS units in H1- 2022(O) as compared to H1-2021.
This was mostly attributable to breakthroughs in veterinary cell culture, and the introduction of spontaneous animal disease models, which can have more variability and so require more time to examine. H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.
The key factor boosting the demand for veterinary biologics is the approval of biological medicinal products for marketing in veterinary use by the EMA.
Additionally, as the market is subject to changes influenced by macroeconomic and industrial factors, the growth of the veterinary biologics market is expected to be influenced by devised alternative methods for control of infectious agents, production of thermostable vaccines for veterinary use, and increasing funding for critical research needs for safe development of veterinary biologics.
Moreover, with the observed increase in the rate of affected companion animals after exposure to diseases from humans, and proposed and documented ethical review of clinical studies by a structured review committee, the market is expected to witness a positive shift in terms of value over the forecasted years.
2014-2021 Veterinary Biologics Market Demand Outlook Compared To 2022-2029 Forecast
Sales of Veterinary Biologics grew at a CAGR of 6.5% between 2014 and 2021.
The primary factors boosting the veterinary biologics market growth are increasing awareness of pet health, rising adoption rates and improving adoption of inducing “herd immunity” in smaller animals.
Rising awareness of pet health and growing incidence of infectious diseases among pets is projected to fuel revenues of the market. In this regard, it has been estimated that even in developed nations, the proportion of vaccinated companion animals varies between 30% and 50% only. This proportion is as less as 10%-15% in developing countries. However, residents in developed countries are ready to spend money to ensure better health of their pets.
In addition rising demand for pet insurance in developed economies is an ongoing trend. It has been projected that not more than 1% of pet dogs in the U.S. have insurance cover. Considering this, FMI expects the global veterinary biologics market to grow at a CAGR of 6.9% through 2029.
Which Factors Are Restraining Demand For Veterinary Biologics?
Risk from compounding therapy failure and gaps in epidemiological knowledge/ data availability are major restraining factor.
FDA reports that compounded animal drug formulations can pose serious complications to animal health. This may be attributed to factors including errors in compounded drug preparations, inappropriate amount of active ingredient, chemical and physical instability, and deficiency of bioavailability in the target patient.
According to the report, the compounded form of the drug contained 70 times the concentration of the FDA-approved drug, leading to the death of 2 horses and adverse reactions in 11 others. The other study conducted in Florida reported the death of 21 Polo horses from a 10 fold overdose of a selenium compound.
There is a large gap in understanding the epidemiology of veterinary diseases due to differences in disease patterns. A typical example is one for the Newcastle Disease for poultry, and the dearth of epidemiological knowledge for it created serious economic losses in the international poultry trade.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-Wise Insights
What Makes the U.S. a Large Market for Veterinary Biologics?
The U.S. is estimated to account for around 87.1% of the North America veterinary biologics market in 2022.
Rebound of economic prosperity in the developed markets has led to an increased demand for processed and healthy meat products. This fuels demand for effective vaccination of livestock, in nations such as U.S. Increasing consumer health awareness leads to rising consumer preference for lean white meat and fish over red meat. This is expected to drive growth of the poultry and aquaculture segment.
The animal health industry has a high impact economically and a large social contribution. Keeping animals healthy also helps in keeping humans healthy, which is further expected to drive demand for veterinary biologics over the forecast period.
This involves 850 prominent scientists, physicians, and veterinarians worldwide. Devising complementary and harmonized approaches to understand disease transmission mechanisms along with protection and persistence could help in more rational design of veterinary vaccines. This could help in better tackling emerging and remerging infections – 70% of which are vector-borne or chronic in nature. All these can drive the demand in U.S market
Why is Germany Considered a Lucrative Veterinary Biologics Market?
Germany is estimated to grow with CAGR 7.2% in the veterinary biologics market in Europe in 2022.
Growing awareness amongst the population regarding animal diseases, rise in the adoption of animal health facilities in Europe and healthcare scheme for companion insurance, which is applied to surge the efficiency of animal healthcare systems in Germany is expected to drive the market growth.
What are the Factors Fueling the Demand for Veterinary Biologics in U.K?
The veterinary biologics market in U.K is estimated to be worth US$ 644.0 Mn in 2022 in the global market.
U.K’s greater attention is on invention on product used in treatment of zoonotic diseases coupled with developments in biotechnology, which is expected to create a favorable platform for development of veterinary vaccines in high-income economies.
These techniques include next-generation sequencing, synthetic biology, and systems biology. Continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency, and shorten time-to-market for new veterinary vaccines.
Also, favorable pet insurance help in rise the adoption of pets in U.K that helps the growth of the market in this region.
How will the Veterinary Biologics Market Expand across India?
Demand for veterinary biologics in India is expected to rise at around 7.7% CAGR over the forecast period.
The increasing prevalence as well as incidence of zoonotic disease are major public health concerns. Zoonotic diseases are transmitted by animals to humans. More than 70% of human infectious diseases are caused by pathogens shared by wild and domestic animals.
The major pathogens and diseases associated with zoonotic are Ebola hemorrhagic fever, anthrax, rift valley fever, brucellosis, Chagas disease, an influenza, severe acute respiratory syndrome (SARS), leptospirosis, cysticercoids and echinococcosis, and toxoplasmas.
Many foodborne zoonotic diseases such as bovine tuberculosis, brucellosis, salmonellosis, and some helminth infections especially occur in low-income and middle-income countries like India creating high risk related to foodborne disease.
Category-Wise Insights
Demand for Vaccines continue gaining Traction
By Product, Vaccines are anticipated to hold the maximum share of 91.4% in 2022, expanding at rate of nearly 6.5% during the forecast period.
Unification of veterinary drugs/biologics research along with research in human medicine is being undertaken through leading nodal healthcare agencies such as the American Medical Association, American Veterinary Medical Association, the American Society of Tropical Medicine and Hygiene, the CDC, the USDA, and the U.S. National Environmental Health Association (NEHA) for development of vaccines. This is anticipated to surge their adoption of vaccines and drive the demand.
Why Livestock will hold the most of the market share?
By Animal Type, Livestock is leading the market and is projected to account for 51.7% of the total market revenue share in 2022.
Increasing demand for the processed animal origin food, high adoption of dairy product and also USDA’s classification of pork, veal, beef, and lamb (mutton) as livestock, and all livestock are all the prime factors generating significant incremental opportunity for livestock animal segment growth in veterinary biologics market.
Why Veterinary Clinics Projected Maximum Growth in the Veterinary Biologics Market?
By distribution channel, veterinary clinics is anticipated to hold the maximum share of 41.3% in 2022, expanding at rapid rate of 7.3% CAGR during the forecast period.
The growing adoption of pet and increasing number of walk-in patient in hospitals is leading to the growing market share of veterinary clinics. Veterinary clinics is the place where all primary care is taken in clinics so most of pet care is done there. Hence an increased share is seen from clinics.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Competitive Landscape
Companies operating in the veterinary biologics market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In July 2020 – Zoetis acquired Benchmark Holdings, PLC, as a strategic addition to its pharma business, which develops and commercializes fish vaccines and offers services in vaccination and diagnostics for aquaculture.
- In March 2021, Elanco Animal Health company launched its newest innovation for Cats, Elura™ (capromorelin oral solution), for chronic kidney diseases to U.S. veterinarians.
Scope Of The Report
|
Attribute |
Details |
|
Forecast Period |
2014-2021 |
|
Historical Data Available for |
2022-2029 |
|
Market Analysis |
USD Billion for Value |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Australia, New Zealand, GCC Countries, South Africa, Turkey |
|
Key Segments Covered |
Product, Animal, Distribution Channel and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Veterinary Biologics Market By Category
By Product
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
By Animal
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is set to expand 1.6X over the forecasted years owing to the rising number of pet adoption and increasing incidence of foodborne and zoonotic diseases.
The sales of veterinary biologics in the market have grown at a CAGR of nearly 6.5% between 2014 and 2021.
The veterinary biologics market is expected to reach US$ 18.2 Bn by the end of 2029 with sales revenue expected to register CAGR of 6.9% over the forecast period.
North America currently holds the largest market share in the veterinary biologics. U.S. being the leading contributor with a market value over US$ 3.1 Bn in 2022.
Demand of veterinary biologics market is expected to register growth in Europe at rate of 6.7% CAGR during the forecast period.
The veterinary biologics in China is likely to observe growth with an impressive CAGR of 8.1% during the forecast period. The market in China is driven by the increasing awareness of pet health in china and growing technological advancements in biologics.
Acquisitions by big players, enhancing direct customer interactions, growing focus on developing protozoan parasitic vaccines, smaller players- limited room for growth and adoption of pet insurance in matured markets are key trends driving sales of veterinary biologics market across the globe.
Japan’s veterinary biologics market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.8% CAGR during the forecast period. South Korea market expected to exhibit healthy growth of 6.3% CAGR during the forecast period.
U.S., China, Italy, U.K, and Germany are the top 5 countries that are driving the demand for Veterinary Biologics market.
Leading companies of veterinary biologics are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.)
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Key Success Factors
4.1. Regulatory Scenario
5. Global Veterinary Biologics Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021and Forecast, 2022-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021
5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.2. Forecast Factors - Relevance & Impact
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis By Product, 2014 - 2021
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2029
7.3.1. Vaccines
7.3.1.1. Attenuated Live Vaccines
7.3.1.2. Conjugate Vaccines
7.3.1.3. Inactivated Vaccines
7.3.1.4. Subunit Vaccines
7.3.1.5. Toxoid Vaccines
7.3.1.6. DNA Vaccines
7.3.1.7. Recombinant Vaccines
7.3.2. Bacterial Extracts
7.3.3. Monoclonal Antibody
7.3.4. Immunomodulators
7.3.4.1. Cytokines
7.3.4.2. Others
7.3.5. Allergenic Extracts
7.4. Market Attractiveness Analysis By Product
8. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal
8.1. Introduction / Key Findings
8.2. Historical Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2014 - 2021
8.3. Current and Future Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2022 - 2029
8.3.1. Companion Animals
8.3.1.1. Canine
8.3.1.2. Avian
8.3.1.3. Feline
8.3.2. Livestock Animals
8.3.2.1. Aquatic
8.3.2.2. Bovine
8.3.2.3. Porcine
8.3.2.4. Ovine/Caprine
8.3.2.5. Poultry
8.3.3. Equine
8.4. Market Attractiveness Analysis of Antitoxins Market By Animal
9. Global Veterinary Biologics - Cytokines Market Analysis 2014-2021 and Forecast 2022-2029, by Animal
9.1. Historical Cytokines Market Size (US$ Mn) Analysis By Animal, 2014 - 2021
9.2. Current and Future Cytokines Market Size (US$ Mn) Analysis By Animal, 2022 - 2029
9.2.1. Companion Animals
9.2.1.1. Canine
9.2.1.2. Avian
9.2.1.3. Feline
9.2.2. Livestock Animals
9.2.2.1. Aquatic
9.2.2.2. Bovine
9.2.2.3. Porcine
9.2.2.4. Ovine/Caprine
9.2.2.5. Poultry
9.2.3. Equine
10. Global Veterinary Biologics - Other Immunomodulatory Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal
10.1. Historical Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2014 - 2021
10.2. Current and Future Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2022 - 2029
10.2.1. Companion Animals
10.2.1.1. Canine
10.2.1.2. Avian
10.2.1.3. Feline
10.2.2. Livestock Animals
10.2.2.1. Aquatic
10.2.2.2. Bovine
10.2.2.3. Porcine
10.2.2.4. Ovine/Caprine
10.2.2.5. Poultry
10.2.3. Equine
11. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2029
11.3.1. Veterinary Clinics
11.3.2. Veterinary Hospitals
11.3.3. Veterinary Research Institutes
11.3.4. Retail Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Animal, 2014 - 2021
12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. South Asia
12.3.5. East Asia
12.3.6. Oceania
12.3.7. Middle East & Africa
12.4. Market Attractiveness Analysis By Region
13. North America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
13.3.1. By Country
13.3.1.1. U.S.
13.3.1.2. Canada
13.3.2. By Product
13.3.3. By Animal
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Animal
13.4.4. By Distribution Channel
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029
14.3.1. By Country
14.3.1.1. Brazil
14.3.1.2. Mexico
14.3.1.3. Rest of Latin America
14.3.2. By Product
14.3.3. By Animal
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Animal
14.4.4. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Europe Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021
15.3. Market Size (US$ Mn) and By Market Taxonomy, 2022 - 2029
15.3.1. By Country
15.3.1.1. Germany
15.3.1.2. Italy
15.3.1.3. France
15.3.1.4. U.K.
15.3.1.5. Spain
15.3.1.6. BENELUX
15.3.1.7. Russia
15.3.1.8. Rest of Europe
15.3.2. By Product
15.3.3. By Animal
15.3.4. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Animal
15.4.4. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Thailand
16.3.1.3. Indonesia
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Animal
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Animal
16.4.4. By Distribution Channel
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
17.1. Introduction
17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021
17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Animal
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Animal
17.4.4. By Distribution Channel
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
18.1. Introduction
18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021
18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029
18.3.1. By Country
18.3.1.1. Australia
18.3.1.2. New Zealand
18.3.2. By Product
18.3.3. By Animal
18.3.4. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Animal
18.4.4. By Distribution Channel
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. MEA Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021
19.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. Turkey
19.4.1.3. Northern Africa
19.4.1.4. South Africa
19.4.1.5. Rest of MEA
19.4.2. By Product
19.4.3. By Animal
19.4.4. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product
19.5.3. By Animal
19.5.4. By Distribution Channel
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
20. Emerging Countries Veterinary Biologics Market Analysis 2022 & 2029
20.1. Introduction
20.1.1. Market Value Proportion Analysis, By Key Countries
20.1.2. Global Vs. Country Growth Comparison
20.2. China Veterinary Biologics Market Analysis
20.2.1. Introduction
20.2.2. PEST Analysis
20.2.3. Market Value Proportion Analysis by Market Taxonomy
20.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.2.4.1. By Product
20.2.4.2. By Animal
20.2.4.3. By Distribution Channel
20.3. India Veterinary Biologics Market Analysis
20.3.1. Introduction
20.3.2. PEST Analysis
20.3.3. Market Value Proportion Analysis by Market Taxonomy
20.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.3.4.1. By Product
20.3.4.2. By Animal
20.3.4.3. By Distribution Channel
20.4. Brazil Veterinary Biologics Market Analysis
20.4.1. Introduction
20.4.2. PEST Analysis
20.4.3. Market Value Proportion Analysis by Market Taxonomy
20.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
20.4.4.1. By Product
20.4.4.2. By Animal
20.4.4.3. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
21.4.1. Product foot print by Players
21.4.2. Channel Foot Print by Players
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Elanco Animal Health
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
22.3.1.4. Sales Footprint
22.3.1.5. Strategy Overview
22.3.1.5.1. Marketing Strategy
22.3.1.5.2. Product Strategy
22.3.1.5.3. Channel Strategy
22.3.2. Ceva
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
22.3.2.4. Sales Footprint
22.3.2.5. Strategy Overview
22.3.2.5.1. Marketing Strategy
22.3.2.5.2. Product Strategy
22.3.2.5.3. Channel Strategy
22.3.3. Phibro Animal Health Corporation
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
22.3.3.4. Sales Footprint
22.3.3.5. Strategy Overview
22.3.3.5.1. Marketing Strategy
22.3.3.5.2. Product Strategy
22.3.3.5.3. Channel Strategy
22.3.4. Boehringer Ingelheim
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
22.3.4.4. Sales Footprint
22.3.4.5. Strategy Overview
22.3.4.5.1. Marketing Strategy
22.3.4.5.2. Product Strategy
22.3.4.5.3. Channel Strategy
22.3.5. Zoetis, Inc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
22.3.5.4. Sales Footprint
22.3.5.5. Strategy Overview
22.3.5.5.1. Marketing Strategy
22.3.5.5.2. Product Strategy
22.3.5.5.3. Channel Strategy
22.3.6. Merck Animal Health
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
22.3.6.4. Sales Footprint
22.3.6.5. Strategy Overview
22.3.6.5.1. Marketing Strategy
22.3.6.5.2. Product Strategy
22.3.6.5.3. Channel Strategy
22.3.7. Virbac
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
22.3.7.4. Sales Footprint
22.3.7.5. Strategy Overview
22.3.7.5.1. Marketing Strategy
22.3.7.5.2. Product Strategy
22.3.7.5.3. Channel Strategy
22.3.8. Hester Biosciences Limited
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
22.3.8.4. Sales Footprint
22.3.8.5. Strategy Overview
22.3.8.5.1. Marketing Strategy
22.3.8.5.2. Product Strategy
22.3.8.5.3. Channel Strategy
22.3.9. Colorado Serum Company
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
22.3.9.4. Sales Footprint
22.3.9.5. Strategy Overview
22.3.9.5.1. Marketing Strategy
22.3.9.5.2. Product Strategy
22.3.9.5.3. Channel Strategy
22.3.10. Addison Biological Laboratory, Inc.
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
22.3.10.4. Sales Footprint
22.3.10.5. Strategy Overview
22.3.10.5.1. Marketing Strategy
22.3.10.5.2. Product Strategy
22.3.10.5.3. Channel Strategy
22.3.11. American Animal Health, Inc.
22.3.11.1. Overview
22.3.11.2. Product Portfolio
22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
22.3.11.4. Sales Footprint
22.3.11.5. Strategy Overview
22.3.11.5.1. Marketing Strategy
22.3.11.5.2. Product Strategy
22.3.11.5.3. Channel Strategy
22.3.12. HIPRA
22.3.12.1. Overview
22.3.12.2. Product Portfolio
22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
22.3.12.4. Sales Footprint
22.3.12.5. Strategy Overview
22.3.12.5.1. Marketing Strategy
22.3.12.5.2. Product Strategy
22.3.12.5.3. Channel Strategy
22.3.13. Bimeda Inc. (Texas Vet Lab, Inc.)
22.3.13.1. Overview
22.3.13.2. Product Portfolio
22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
22.3.13.4. Sales Footprint
22.3.13.5. Strategy Overview
22.3.13.5.1. Marketing Strategy
22.3.13.5.2. Product Strategy
22.3.13.5.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 02: Global Veterinary Cytokines Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 03: Global Veterinary Other Immunomodulatory Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 04: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 05: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 06: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region
Table 07: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 08: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 09: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 10: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 11: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 12: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 13: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 14: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 15: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 16: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 17: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 18: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 19: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 20: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 21: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 22: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 23: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 24: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 25: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 26: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 27: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 28: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 29: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 30: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 31: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country
Table 32: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 33: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 34: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 35: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 36: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 37: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 38: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 39: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 40: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Table 41: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product
Table 42: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal
Table 43: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global veterinary biologics Historical Market Size and Y-o-Y, 2014-2021
Figure 02: Global veterinary biologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029
Figure 03: Global veterinary biologics Market Absolute $ Opportunity, 2014–2029
Figure 04: Global Veterinary Biologics Market Share Analysis (%) By Product, 2022 & 2029
Figure 05: Global Veterinary Biologics Market Y-o-Y Growth (%) By Product, 2022–2029
Figure 06: Global Veterinary Biologics Market Attractiveness Analysis, By Product
Figure 07: Global Veterinary Biologics Market Share Analysis (%) By Animal, 2022 & 2029
Figure 08: Global Veterinary Biologics Market Y-o-Y Growth (%) By Animal, 2022–2029
Figure 09: Global Veterinary Biologics Market Attractiveness Analysis, By Animal
Figure 10: Global Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 11: Global Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 12: Global Veterinary Biologics Market Attractiveness Analysis, By Distribution Channel
Figure 13: Global Veterinary Biologics Market Share Analysis (%) By Region, 2022 & 2029
Figure 14: Global Veterinary Biologics Market Y-o-Y Growth (%) By Region, 2022–2029
Figure 15: Global Veterinary Biologics Market Attractiveness Analysis, By Region
Figure 16: North America Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 17: North America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 18: North America Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 19: North America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 20: North America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 21: North America Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 22: North America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 23: North America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 24: North America Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 25: North America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 26: North America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 27: North America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 28: North America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 29: North America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 30: Latin America Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 31: Latin America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 32: Latin America Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 33: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 34: Latin America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 35: Latin America Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 36: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 37: Latin America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 38: Latin America Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 39: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 40: Latin America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 41: Latin America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 42: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 43: Latin America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 44: Europe Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 45: Europe Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 46: Europe Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 47: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 48: Europe Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 49: Europe Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 50: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 51: Europe Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 52: Europe Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 53: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 54: Europe Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 55: Europe Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 56: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 57: Europe Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 58: South Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 59: South Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 60: South Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 61: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 62: South Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 63: South Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 64: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 65: South Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 66: South Asia Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 67: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 68: South Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 69: South Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 70: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 71: South Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 72: East Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 73: East Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 74: East Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 75: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 76: East Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 77: East Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 78: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 79: East Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 80: East Asia Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 81: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 82: East Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 83: East Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 84: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 85: East Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 86: Oceania Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 87: Oceania Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 88: Oceania Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 89: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 90: Oceania Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 91: Oceania Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 92: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 93: Oceania Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 94: Oceania Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 95: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 96: Oceania Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 97: Oceania Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 98: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 99: Oceania Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 100: MEA Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 101: MEA Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 102: MEA Veterinary Biologics Market Analysis by Country – 2022 & 2029
Figure 103: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029
Figure 104: MEA Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029
Figure 105: MEA Veterinary Biologics Market Analysis by Product – 2022 & 2029
Figure 106: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029
Figure 107: MEA Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 108: MEA Veterinary Biologics Market Analysis by Animal –2022 & 2029
Figure 109: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029
Figure 110: MEA Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 111: MEA Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029
Figure 112: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029
Figure 113: MEA Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 114: Emerging countries Veterinary Biologics Market Size (US$ Mn) Analysis, 2022
Figure 115: Emerging countries Veterinary Biologics Market Size (US$ Mn) 2014 – 2029
Figure 116: China Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 117: China Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 118: China Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 119: China Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 120: China Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 121: India Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 122: India Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 123: India Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 124: India Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 125: India Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Figure 126: Brazil Veterinary Biologics Market Size (US$ Mn), 2014-2021
Figure 127: Brazil Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029
Figure 128: Brazil Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029
Figure 129: Brazil Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029
Figure 130: Brazil Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
